PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19393624-6	2009	In addition, potent NADPH oxidase inhibitors apocynin and diphenyleneiodonium (DPI) inhibited FMLP mediated cytosolic Ca(2+) release.	diphenyleneiodonium	58-77	formyl peptide receptor 1	Homo sapiens	94-98	
19393624-6	2009	In addition, potent NADPH oxidase inhibitors apocynin and diphenyleneiodonium (DPI) inhibited FMLP mediated cytosolic Ca(2+) release.	diphenyleneiodonium	79-82	formyl peptide receptor 1	Homo sapiens	94-98	
10986013-12	2000	Preincubation with the NADPH oxidase inhibitor diphenyleneiodonium and diethyldithiocarbamate, which inhibits superoxide dismutase, led to an almost complete reduction of DCF fluorescence in response to TMCH, fMLP, and PMA.	diphenyleneiodonium	47-66	formyl peptide receptor 1	Homo sapiens	209-213	
15450937-3	2004	Inclusion of diphenylene iodonium chloride (DPI, 10 microM), an inhibitor of NADPH oxidase, antagonised the effects of CA on NADPH oxidase activity and the membrane repolarisation responses of FMLP-activated neutrophils, but failed to restore store-operated influx of Ca2+.	diphenyleneiodonium	13-42	formyl peptide receptor 1	Homo sapiens	193-197	
15450937-3	2004	Inclusion of diphenylene iodonium chloride (DPI, 10 microM), an inhibitor of NADPH oxidase, antagonised the effects of CA on NADPH oxidase activity and the membrane repolarisation responses of FMLP-activated neutrophils, but failed to restore store-operated influx of Ca2+.	diphenyleneiodonium	44-47	formyl peptide receptor 1	Homo sapiens	193-197	
11432850-4	2001	Phorbol 12-myristate 13-acetate, guanosine 5"-3-O- (thio)triphosphate (GTP gamma S), or FMLP stimulated a similar diphenylene iodonium-sensitive diaphorase activity pattern in neutrophils and in differentiated parent PLB-985 cells.	diphenyleneiodonium	114-134	formyl peptide receptor 1	Homo sapiens	88-92	
15163557-4	2004	DPI, added to the cells at the time of maximum FMLP-activated membrane depolarisation, accelerated the rates of both membrane repolarisation and influx of Ca(2+), while KB-R7943 effectively antagonised these processes.	diphenyleneiodonium	0-3	formyl peptide receptor 1	Homo sapiens	47-51	
2843166-1	1988	NADPH-dependent superoxide production by intact human neutrophils is inhibited by DPI (diphenyleneiodonium), when stimulated by either FMLP (N-formylmethionyl-leucyl-phenylalanine) or PMA (phorbol 12-myristate 13-acetate).	diphenyleneiodonium	82-85	formyl peptide receptor 1	Homo sapiens	135-139	
2843166-1	1988	NADPH-dependent superoxide production by intact human neutrophils is inhibited by DPI (diphenyleneiodonium), when stimulated by either FMLP (N-formylmethionyl-leucyl-phenylalanine) or PMA (phorbol 12-myristate 13-acetate).	diphenyleneiodonium	87-106	formyl peptide receptor 1	Homo sapiens	135-139	
2843166-5	1988	Degranulation of the azurophil and specific granules, induced by the soluble stimuli FMLP or PMA, and by particulate stimuli was decreased by the presence of DPI.	diphenyleneiodonium	158-161	formyl peptide receptor 1	Homo sapiens	85-89	
26634216-7	2015	Hydroxy-3-methoxyaceto-phenone (HMAP), diphenyleneiodonium (DPI), and siRNA Nox2 reduced the ROS and IL-8 release in neutrophils treated with fMLP.	diphenyleneiodonium	39-58	formyl peptide receptor 1	Homo sapiens	142-146	
26634216-7	2015	Hydroxy-3-methoxyaceto-phenone (HMAP), diphenyleneiodonium (DPI), and siRNA Nox2 reduced the ROS and IL-8 release in neutrophils treated with fMLP.	diphenyleneiodonium	60-63	formyl peptide receptor 1	Homo sapiens	142-146	
26634216-9	2015	DPI and HMAP reduced NF-kappaB translocation induced by fMLP.	diphenyleneiodonium	0-3	formyl peptide receptor 1	Homo sapiens	56-60